News | February 11, 2022
India’s first mRNA vaccine should be ready soon
It is being developed by Pune-based Gennova Biopharmaceuticals
It is being developed by Pune-based Gennova Biopharmaceuticals
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
The Home Healthcare market is expected to be US $ 14.2 by 2025
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
The total cost of the project is estimated at Rs 30 crore
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Subscribe To Our Newsletter & Stay Updated
